Please wait
false 2026-03-31 --09-30 0001816815 0001816815 2025-10-01 2026-03-31 0001816815 2026-03-31 0001816815 2025-09-30 0001816815 us-gaap:CommonClassAMember 2026-03-31 0001816815 us-gaap:CommonClassAMember 2025-09-30 0001816815 us-gaap:CommonClassBMember 2026-03-31 0001816815 us-gaap:CommonClassBMember 2025-09-30 0001816815 2024-10-01 2025-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-09-30 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-09-30 0001816815 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001816815 BON:StatutoryReserveMember 2024-09-30 0001816815 us-gaap:RetainedEarningsMember 2024-09-30 0001816815 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001816815 BON:TotalShareholdersEquityMember 2024-09-30 0001816815 us-gaap:NoncontrollingInterestMember 2024-09-30 0001816815 2024-09-30 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-09-30 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-09-30 0001816815 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001816815 BON:StatutoryReserveMember 2025-09-30 0001816815 us-gaap:RetainedEarningsMember 2025-09-30 0001816815 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001816815 BON:TotalShareholdersEquityMember 2025-09-30 0001816815 us-gaap:NoncontrollingInterestMember 2025-09-30 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-10-01 2025-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-10-01 2025-03-31 0001816815 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2025-03-31 0001816815 BON:StatutoryReserveMember 2024-10-01 2025-03-31 0001816815 us-gaap:RetainedEarningsMember 2024-10-01 2025-03-31 0001816815 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2025-03-31 0001816815 BON:TotalShareholdersEquityMember 2024-10-01 2025-03-31 0001816815 us-gaap:NoncontrollingInterestMember 2024-10-01 2025-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-10-01 2026-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-10-01 2026-03-31 0001816815 us-gaap:AdditionalPaidInCapitalMember 2025-10-01 2026-03-31 0001816815 BON:StatutoryReserveMember 2025-10-01 2026-03-31 0001816815 us-gaap:RetainedEarningsMember 2025-10-01 2026-03-31 0001816815 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-01 2026-03-31 0001816815 BON:TotalShareholdersEquityMember 2025-10-01 2026-03-31 0001816815 us-gaap:NoncontrollingInterestMember 2025-10-01 2026-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-03-31 0001816815 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001816815 BON:StatutoryReserveMember 2025-03-31 0001816815 us-gaap:RetainedEarningsMember 2025-03-31 0001816815 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001816815 BON:TotalShareholdersEquityMember 2025-03-31 0001816815 us-gaap:NoncontrollingInterestMember 2025-03-31 0001816815 2025-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-03-31 0001816815 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-03-31 0001816815 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001816815 BON:StatutoryReserveMember 2026-03-31 0001816815 us-gaap:RetainedEarningsMember 2026-03-31 0001816815 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001816815 BON:TotalShareholdersEquityMember 2026-03-31 0001816815 us-gaap:NoncontrollingInterestMember 2026-03-31 0001816815 BON:NonControllingMember 2026-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft BON:Integer iso4217:CNY

 

 

BON NATURAL LIFE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

       
   As of 
   March 31, 2026   September 30, 2025 
   (UNAUDITED)     
ASSETS          
CURRENT ASSETS          
Cash  $5,781,655   $3,765,978 
Restricted cash   3,400,000    2,500,000 
Accounts receivable, net   10,094,732    11,012,741 
Inventories, net   3,724,699    3,305,438 
Advances to suppliers, net   10,749,442    15,938,109 
Due from related parties   

339,640

    527,389 
Prepaid expenses and other current assets   

16,777,335

    8,710,796 
TOTAL CURRENT ASSETS  $50,867,503   $45,760,451 
NON-CURRENT ASSETS          
Property, plant and equipment, net  $22,736,468   $18,158,289 
Intangible assets, net   6,436,108    6,424,893 
Right-of-use leased assets, net   157,625    113,250 
Non-current other receivables   -    14,728,732 
TOTAL NON-CURRENT ASSETS  $29,330,201   $39,425,164 
TOTAL ASSETS  $80,197,704   $85,185,615 
           
LIABILITIES AND EQUITY          
CURRENT LIABILITIES          
Short-term loans  $10,214,136   $10,248,225 
Current portion of long-term loans   492,896    1,081,613 
Accounts payable   8,590,992    7,641,274 
Due to related parties   694,420    134,073 
Taxes payable   5,183,627    4,881,898 
Deferred revenue   226,773    219,678 
Accrued expenses and other current liabilities   2,391,420    2,024,902 
Operating lease liabilities, current   56,206    76,797 
TOTAL CURRENT LIABILITIES  $

27,850,470

   $26,308,460 
NON-CURRENT LIABILITIES          
Long-term loans   1,464,193    842,815 
Operating lease liabilities, non-current   102,846    36,601 
TOTAL NON-CURRENT LIABILITIES  $1,567,039   $879,416 
TOTAL LIABILITIES  $

29,417,509

   $27,187,876 
           
SHAREHOLDERS’ EQUITY          
Class A Ordinary shares ($0.025 par value, 1,000,000,000 shares authorized, 6,126,971 and 6,086,971 shares issued and outstanding as of March 31, 2026 and September 30, 2025, respectively)  $153,174   $152,174 
Class B Ordinary shares ($0.001 par value, 50,000,000 shares authorized, 2,041,839 shares issued and outstanding as of March 31, 2026 and September 30, 2025)   2,042    2,042 
Additional paid-in capital   41,285,390    40,791,764 
Statutory reserve   2,849,440    2,849,440 
Retained earnings   7,429,700    16,630,831 
Accumulated other comprehensive (loss)   (939,551)   (2,875,571)
TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS’ EQUITY  $50,780,195   $57,550,680 
NON-CONTROLLING INTEREST  $-   $447,059 
TOTAL SHAREHOLDERS’ EQUITY  $

50,780,195

   $57,997,739 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $80,197,704   $85,185,615 

 

 

 

 

BON NATURAL LIFE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

       
   For the six months ended March 31, 
   2026   2025 
REVENUE  $8,097,810   $7,949,845 
Cost of revenue   (5,910,610)   (6,041,997)
GROSS PROFIT   2,187,200    1,907,848 
           
OPERATING EXPENSES          
Selling expenses   (410,216)   (68,317)
General and administrative expenses   (1,993,886)   (1,459,009)
Provision for credit losses   (5,656,888)   - 
Impairment losses on advances to suppliers   

(1,920,508

)   - 
Research and development expenses   (781,094)   (96,472)
TOTAL OPERATING EXPENSES   (10,762,592)   (1,623,798)
           
(LOSS) INCOME FROM OPERATIONS   (8,575,392)   284,050 
           
OTHER INCOME (EXPENSES)          
Interest income   149    116 
Interest expenses   (252,168)   (164,584)
Gain from disposal of subsidiary   57,813    - 
Other (losses) income   (434,792)   193,582 
TOTAL OTHER EXPENSES, NET   (628,998)   29,114 
           
(LOSS) INCOME BEFORE INCOME TAX PROVISION   (9,204,390)   313,164 
           
INCOME TAX PROVISION   -    (177,253)
           
NET (LOSS) INCOME   (9,204,390)   135,911 
Less: net (loss) attributable to non-controlling interest   (3,259)   (33,316)
NET (LOSS) INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED  $(9,201,131)  $169,227 
           
OTHER COMPREHENSIVE INCOME (LOSS)          
Total foreign currency transaction adjustment   1,927,646    (1,419,950)
TOTAL COMPREHENSIVE (LOSS)   (7,276,744)   (1,284,039)
Less: comprehensive (loss) attributable to non-controlling interest   

(11,633

)   (59,435)
COMPREHENSIVE (LOSS) ATTRIBUTABLE TO BON NATURAL LIFE LIMITED  $(7,265,111)  $(1,224,604)
           
(LOSS) EARNINGS PER SHARE          
Basic  $(1.51)  $0.56 
Diluted  $(1.51)  $0.50 
           
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING          
Basic   6,090,487    302,647 
Diluted   6,090,487    336,070 

 

 

 

 

BON NATURAL LIFE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED MARCH 31, 2026 AND 2025

(UNAUDITED)

 

   Shares      Shares                         
   Class A Ordinary Shares   Class B Ordinary Shares   Additional paid-in    Statutory    Retained    Accumulated other comprehensive    Total Bon Natural Life Limited shareholders’    Non-controlling    Total  
   Shares   Amount   Shares   Amount   capital   reserve   earnings   (loss)   equity   interest   equity 
Balance as of September 30, 2024   77,149   $1,928    2,041,839   $2,042   $25,005,100   $2,733,354   $18,741,685   $(2,577,418)  $43,906,691   $         442,848   $44,349,539 
Issuance of Class A Ordinary Shares for a public offering, net   3,590,528    89,763    -    -    10,454,042    -    -    -    10,543,805    -    10,543,805 
Share-based compensation   8,000    200    -    -    295,800    -    -    -    296,000    -    296,000 
Net income (loss)   -    -    -    -    -    -    169,227    -    169,227    (33,316)   135,911 
Foreign currency translation adjustment   -    -    -    -    -    -    -    (1,393,831)   (1,393,831)   (26,119)   (1,419,950)
Balance as of March 31, 2025   3,675,677   $91,891    2,041,839   $2,042   $35,754,942   $2,733,354   $18,910,912   $(3,971,249)  $53,521,892   $383,413   $53,905,305 
                                                        
Balance as of September 30, 2025   6,086,971    152,174    2,041,839    2,042    40,791,764    2,849,440    16,630,831    (2,875,571)   57,550,680    447,059    57,997,739 
Share-based compensation   40,000    1,000    -    -    58,200    -    -    -    59,200    -    59,200 
Net (loss)   -    -    -    -    -    -    (9,201,131)   -    (9,201,131)   (3,259)   (9,204,390)
Acquisition of the remaining 25% non-controlling interest in a subsidiary   -    -    -    -    435,426    -    -    -    435,426    (435,426)   - 
Foreign currency translation adjustment   -    -    -    -    -    -    -    1,936,020    1,936,020    (8,374)   1,927,646 
Balance as of March 31, 2026   6,126,971   $153,174    2,041,839   $2,042   $41,285,390   $2,849,440   $7,429,700   $(939,551)  $50,780,195   $-   $50,780,195 

 

 

 

 

BON NATURAL LIFE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASHFLOWS

(UNAUDITED)

 

       
   For the six months ended March 31, 
   2026   2025 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net (loss) income  $(9,204,390)  $135,911 
Adjustments to reconcile net loss (income) to cash provided by operating activities:          
Gain from disposal of subsidiary   (57,813)   - 
Loss from disposal of property, plant and equipment   44,095    - 
Provision for credit losses   5,656,888    - 
Impairment losses on advances to suppliers   

1,920,508

    - 
Depreciation and amortization   790,724    617,343 
Amortization of operating lease right-of-use assets   89,480    107,519 
Share-based compensation   59,200    296,000 

Amortization of deferred share-based compensation

   

1,106,968

    

-

 
Unrealized foreign currency exchange (loss)   

-

    

(79,848

)
Changes in operating assets and liabilities:          
Accounts receivable   432,786    361,239 
Inventories   (308,528)   232,466 
Advances to suppliers, net   3,485,897    9,964,799 
Prepaid expenses and other current assets   1,241,265    4,758,681 
Long-term other receivable   -    (14,500,947)
Accounts payable   592,077    (1,219,138)
Operating lease liabilities   (88,226)   (128,902)
Taxes payable   143,255    (753,138)
Deferred revenue   56    (249,910)
Accrued expenses and other current liabilities   518,541   (3,837,742)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES  $6,422,783   $(4,295,667)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Capital expenditure on construction-in-progress   (4,275,444)   - 
Proceeds from disposal of property and equipment   6,095    4,395 
Net cash disposed of on disposal of subsidiary   

(14,358

)   - 
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES  $(4,283,707)  $4,395 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Net proceeds from issuance of Class A Ordinary shares   -    10,543,805 
Proceeds from short-term loans   5,103,746    7,232,644 
Proceeds from long-term loans   713,669    - 
Repayment of short-term loans   (5,460,580)   (5,276,345)
Repayment of long-term loans   (742,215)   (124,467)
Proceeds (repayment) of borrowings from related parties   747,961   (53,393)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES  $

362,581

  $12,322,244 
           
Effect of changes of foreign exchange rates on cash  $

414,020

  $205,876 
Net increase in cash and restricted cash  $2,915,677  $8,236,848 
Cash and restricted cash, beginning of period  $6,265,978   $657,205 
Cash and restricted cash, end of period  $9,181,655   $8,894,053 
           
Supplemental disclosure of cash flow information          
Cash paid for interest expenses  $256,976   $164,584 
Cash paid for income taxes  $-   $- 
           
Supplemental disclosure of non-cash investing and financing activities          
Property and equipment additions through advances to suppliers and accounts payable  $308,659   $- 
Right-of-use assets obtained in exchange for operating lease obligations  $129,598   $- 
Acquisition of non-controlling interest settled through payable 

$

7,137  

$

-